Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05303519
Title Safusidenib Phase 2 Study in IDH1 Mutant Glioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors AnHeart Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
St. Joseph's Hospital and Medical Center RECRUITING Phoenix Arizona 85013 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02214 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Columbia University Medical Center RECRUITING New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Duke Cancer Institute NOT_YET_RECRUITING Durham North Carolina 27710 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44106 United States Details
Huntsman Cancer Insititute, University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
UVA Health, Emily Couric Clinical Cancer Cente RECRUITING Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field